Biosimilars 2017
-
This conference gives you a thorough update on the challenges when developing a biosimilar and also addresses the market access necessities.50.107231 8.760652
| Wann |
21.06.2017 um 09:00 bis 22.06.2017 um 15:30 |
|---|---|
| Veranstaltungsort | Sheraton Offenbach |
| Stadt | Frankfurt/Offenbach |
| Kontaktname | Dr. Henriette Wolf-Klein |
| Kontakttelefon | +49 6221 500 680 |
| Zielgruppe |
This conference addresses the needs of managers in the pharmaceutical industry who work with biosimilars. Those working in the following areas will particularly benefit from this event: - Marketing authorisation - Clinical and preclinical development - CMC/quality and analytics - Market access and business development - Legal affairs/patent protection |
| Termin übernehmen |
vCal
iCal
|
Do you work in biosimilars or intend to do so? Then you should not miss this conference with leading biosimilars experts. During the two conference days, you will receive a full update from development requirements, to marketing authorisation requirements through to reimbursement topics. I would be very pleased to welcome you on the 21st June at the conference! Dr Henriette Wolf-Klein Department Manager Pharma & Healthcare
- Substitution and interchangeability
- current status in Germany, the EU and the US
- Extrapolation of indications - remaining challenges
- SPC and patents - managing product protection life cycles
- Key considerations for combination products
- Analytical development and comparability exercises
Weitere Informationen über diesen Termin…
FORUM Institut für Management GmbH
Programm
1706231.pdf
—
PDF document,
238 kB (244,491 bytes)
